164 related articles for article (PubMed ID: 38117448)
1. Neuroprotective and Anti-inflammatory Effects of Rubiscolin-6 Analogs with Proline Surrogates in Position 2.
Perlikowska R; Silva J; Alves C; Susano P; Zakłos-Szyda M; Skibska A; Adamska-Bartłomiejczyk A; Wtorek K; do Rego JC; do Rego JL; Kluczyk A; Pedrosa R
Neurochem Res; 2024 Apr; 49(4):895-918. PubMed ID: 38117448
[TBL] [Abstract][Full Text] [Related]
2. The Therapeutic Potential of Naturally Occurring Peptides in Counteracting SH-SY5Y Cells Injury.
Perlikowska R; Silva J; Alves C; Susano P; Pedrosa R
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233079
[TBL] [Abstract][Full Text] [Related]
3. MiR-410 exerts neuroprotective effects in a cellular model of Parkinson's disease induced by 6-hydroxydopamine via inhibiting the PTEN/AKT/mTOR signaling pathway.
Ge H; Yan Z; Zhu H; Zhao H
Exp Mol Pathol; 2019 Aug; 109():16-24. PubMed ID: 31067440
[TBL] [Abstract][Full Text] [Related]
4. Protective Effects of Fisetin Against 6-OHDA-Induced Apoptosis by Activation of PI3K-Akt Signaling in Human Neuroblastoma SH-SY5Y Cells.
Watanabe R; Kurose T; Morishige Y; Fujimori K
Neurochem Res; 2018 Feb; 43(2):488-499. PubMed ID: 29204750
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective Effects of Polysaccharides and Gallic Acid from
Rangsinth P; Pattarachotanant N; Wang W; Shiu PH; Zheng C; Li R; Tencomnao T; Chuchawankul S; Prasansuklab A; Cheung TM; Li J; Leung GP
Molecules; 2024 Feb; 29(5):. PubMed ID: 38474465
[TBL] [Abstract][Full Text] [Related]
6. p-Hydroxybenzyl Alcohol Antagonized the ROS-Dependent JNK/Jun/Caspase-3 Pathway to Produce Neuroprotection in a Cellular Model of Parkinson's Disease.
Lai MC; Liu WY; Liou SS; Liu IM
Nutrients; 2022 Nov; 14(23):. PubMed ID: 36501032
[TBL] [Abstract][Full Text] [Related]
7. Rubiscolins - Highly Potent Peptides Derived from Plant Proteins.
Perlikowska R; Janecka A
Mini Rev Med Chem; 2018; 18(2):104-112. PubMed ID: 28462718
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotection by marine-derived compound, 11-dehydrosinulariolide, in an in vitro Parkinson's model: a promising candidate for the treatment of Parkinson's disease.
Chen WF; Chakraborty C; Sung CS; Feng CW; Jean YH; Lin YY; Hung HC; Huang TY; Huang SY; Su TM; Sung PJ; Sheu JH; Wen ZH
Naunyn Schmiedebergs Arch Pharmacol; 2012 Mar; 385(3):265-75. PubMed ID: 22119889
[TBL] [Abstract][Full Text] [Related]
9. Mesencephalic astrocyte-derived neurotrophic factor alleviated 6-OHDA-induced cell damage via ROS-AMPK/mTOR mediated autophagic inhibition.
Zhang J; Cai Q; Jiang M; Liu Y; Gu H; Guo J; Sun H; Fang J; Jin L
Exp Gerontol; 2017 Mar; 89():45-56. PubMed ID: 28099881
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the neuroprotective potential of caffeic acid phenethyl ester in a cellular model of Parkinson's disease.
Turan D; Abdik H; Sahin F; Avşar Abdik E
Eur J Pharmacol; 2020 Sep; 883():173342. PubMed ID: 32634439
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of glyceryl nonivamide against microglia-like cells and 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y human dopaminergic neuroblastoma cells.
Lin YC; Uang HW; Lin RJ; Chen IJ; Lo YC
J Pharmacol Exp Ther; 2007 Dec; 323(3):877-87. PubMed ID: 17855475
[TBL] [Abstract][Full Text] [Related]
12. Citronellol Prevents 6-OHDA-Induced Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis in Parkinson Disease Model of SH-SY5Y Cells via Modulating ROS-NO, MAPK/ERK, and PI3K/Akt Signaling Pathways.
Shao J; Liu X; Lian M; Mao Y
Neurotox Res; 2022 Dec; 40(6):2221-2237. PubMed ID: 36097250
[TBL] [Abstract][Full Text] [Related]
13. 3,4-dihydroxybenzalacetone protects against Parkinson's disease-related neurotoxin 6-OHDA through Akt/Nrf2/glutathione pathway.
Gunjima K; Tomiyama R; Takakura K; Yamada T; Hashida K; Nakamura Y; Konishi T; Matsugo S; Hori O
J Cell Biochem; 2014 Jan; 115(1):151-60. PubMed ID: 23959789
[TBL] [Abstract][Full Text] [Related]
14. Aqueous Extract of Davallia mariesii Attenuates 6-Hydroxydopamine-Induced Oxidative Damage and Apoptosis in B35 Cells Through Inhibition of Caspase Cascade and Activation of PI3K/AKT/GSK-3β Pathway.
Wu CR; Chang HC; Cheng YD; Lan WC; Yang SE; Ching H
Nutrients; 2018 Oct; 10(10):. PubMed ID: 30301204
[TBL] [Abstract][Full Text] [Related]
15. Celastrol attenuates 6-hydroxydopamine-induced neurotoxicity by regulating the miR-146a/PI3K/Akt/mTOR signaling pathways in differentiated rat pheochromocytoma cells.
Guo L; Qu B; Song C; Zhu S; Gong N; Sun J
J Affect Disord; 2022 Nov; 316():233-242. PubMed ID: 35981627
[TBL] [Abstract][Full Text] [Related]
16. Eucommia ulmoides Oliv. bark. attenuates 6-hydroxydopamine-induced neuronal cell death through inhibition of oxidative stress in SH-SY5Y cells.
Kwon SH; Ma SX; Hong SI; Kim SY; Lee SY; Jang CG
J Ethnopharmacol; 2014 Feb; 152(1):173-82. PubMed ID: 24440915
[TBL] [Abstract][Full Text] [Related]
17. Activation of AMPK and inactivation of Akt result in suppression of mTOR-mediated S6K1 and 4E-BP1 pathways leading to neuronal cell death in in vitro models of Parkinson's disease.
Xu Y; Liu C; Chen S; Ye Y; Guo M; Ren Q; Liu L; Zhang H; Xu C; Zhou Q; Huang S; Chen L
Cell Signal; 2014 Aug; 26(8):1680-1689. PubMed ID: 24726895
[TBL] [Abstract][Full Text] [Related]
18. Trametenolic acid B protects against cerebral ischemia and reperfusion injury through modulation of microRNA-10a and PI3K/Akt/mTOR signaling pathways.
Wang J; Wang A; He H; She X; He Y; Li S; Liu L; Luo T; Huang N; Luo H; Zou K
Biomed Pharmacother; 2019 Apr; 112():108692. PubMed ID: 30798122
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective Effect of Luteolin-7-O-Glucoside against 6-OHDA-Induced Damage in Undifferentiated and RA-Differentiated SH-SY5Y Cells.
Rehfeldt SCH; Silva J; Alves C; Pinteus S; Pedrosa R; Laufer S; Goettert MI
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328335
[TBL] [Abstract][Full Text] [Related]
20. Protective Effects of Jujubosides on 6-OHDA-Induced Neurotoxicity in SH-SY5Y and SK-N-SH Cells.
Chen CH; Hsu PC; Hsu SW; Hong KT; Chen KY; He JL; Cho DY; Wang YC; Chang WS; Bau DT; Tsai CW
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
